- Our Letter to the Editor Advocating for Patients Published in Gastroenterology (02/2/2024)
Recently, a group of researchers published their recommendations for standardizing celiac disease clinical trials. While on the whole we agree with the content, we were dismayed to learn that no patients or patient organizations had been consulted to develop these guidelines. We are proud to say that our response, a letter to the editor, was recently published in Gastroenterology.
- Multiple courses of antibiotics may play role in celiac disease development for at-risk children, study finds (01/9/2024)
If a child at risk for celiac disease is prescribed antibiotics multiple times, it may increase the chance that celiac disease will develop, according to a new study. Antibiotics were tied to an increase in a protein that loosens the connection between cells in the intestine. In the future, tests for that protein might be used to determine who is likely to develop celiac disease.
- Healthcare disparities may contribute to underdiagnosis of celiac disease (10/31/2023)
A higher income, living in an urban area and living close to a celiac disease center are all positively correlated with celiac disease prevalence, while being Black or Latino/Hispanic is negatively correlated, according to our research poster presented at Digestive Disease Week 2023.
- LILY Study launches to test monoclonal antibody treatment for celiac disease (09/20/2023)
This new phase 1 trial does not include a gluten challenge
- In kids with celiac disease with no symptoms, tests still find evidence of gluten in their diets (09/19/2023)
A recent study found that children who had detectable gluten in urine and stool samples did not have symptoms, backing up earlier evidence that symptoms are not reliable indicators of gluten getting into the gluten-free diet.